Form 8-K - Current report:
SEC Accession No. 0001171843-25-002148
Filing Date
2025-04-10
Accepted
2025-04-10 16:06:05
Documents
13
Period of Report
2025-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_041025.htm   iXBRL 8-K 21251
  Complete submission text file 0001171843-25-002148.txt   196239

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE anik-20250404.xsd EX-101.SCH 3030
3 XBRL LABEL FILE anik-20250404_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE anik-20250404_pre.xml EX-101.PRE 22799
15 EXTRACTED XBRL INSTANCE DOCUMENT f8k_041025_htm.xml XML 3726
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 25828378
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)